Abstract: The present invention relates to a novel naphthyridinone derivative compound, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, which are each relevant to a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a method for inhibiting ENPP1.
Type:
Application
Filed:
December 29, 2021
Publication date:
May 2, 2024
Applicant:
TXINNO BIOSCIENCE INC.
Inventors:
Seo Jung Han, Chan Sun Park, Sung Joon Kim, Jae Eun Cheong, Jung Hwan Choi, Ali Imran, Sun Woo Lee, Yong Yea Park, Ah Ran Yu, Sun Young Park
Abstract: The present invention relates to a novel benzotriazole derivative compound, a tautomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, which are related to a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a method for inhibiting ENPP1.
Type:
Application
Filed:
January 28, 2022
Publication date:
April 11, 2024
Applicant:
TXINNO BIOSCIENCE INC.
Inventors:
Chan Sun Park, Sung Joon Kim, Ali Imran, Yoo Jin Na, So Ra Paik, Jung Hwan Choi, Sun Woo Lee, Yong Yea Park, Ah Ran Yu, Sun Young Park
Abstract: The present invention relates to a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a novel phthalazine derivative compound related to a method for inhibiting ENPP1, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof.
Type:
Application
Filed:
May 7, 2021
Publication date:
May 25, 2023
Applicant:
TXINNO BIOSCIENCE INC.
Inventors:
Seo Jung Han, Jun Won Choi, Sang Hee Lee, Chan Sun Park, Sung Joon Kim, Jae Eun Cheong, Hee Jin Jeong, Do Hee Oh